Type II Variation [Regulatives / Guidelines]

posted by Elena – Macedonia, 2013-09-18 14:55 (4661 d 20:17 ago) – Posting: # 11518
Views: 6,334

Dear Dr Dan,

Thank you for your response.

Reviewing the available literature I came across this presentation 3-2 Biobatch considerations for quality.
According the information on slide 4 "A biobatch of < 100,000 units may be accepted, but then no scale-up is allowed. This should be clearly indicated in reports for the product, as it affects allowable variations."

This information was the reason for the concern raised.

Could you please indicate a guideline/regulation which states that the scale up is possible even if the biobatch is < 100,000 units.

Kind regards,

Elena

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
132 visitors (0 registered, 132 guests [including 14 identified bots]).
Forum time: 11:13 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5